Literature DB >> 27613302

[Tumorigenesis from a pathological perspective : Tumor spread and epigenetically regulated genes in bladder cancer].

N T Gaisa1.   

Abstract

The article describes the tumorigenesis of bladder cancer from a pathological perspective in three dimensions: morphology, genetics and epigenetics. Field cancerization and tumor cell migration/seeding are the two main hypotheses used for explaining synchronous and metachronous tumors in the urinary tract. By detailed histological mapping of completely embedded cystectomy specimens we found a single tumor focus in nearly 2/3 of the bladders accompanied by surrounding preinvasive carcinoma in situ. We substantiated our findings by studies analyzing TP53 mutations and loss of heterozygosity in various tumor sites. Identical TP53 mutations suggested a clonal relationship of the tumor foci. In situ lineage tracing via cytochrome C oxidase and succinate dehydrogenase enzyme histochemistry and subsequent mitochondrial DNA mutation analysis for definitive evidence of a clonal relationship in bladder tumors remained inconclusive. We found indications for both theories but intraurothelial migration/seeding was more prominent.A further mechanism in tumorigenesis is gene inactivation by epigenetic DNA methylation. We analyzed DNA methylation of various genes, which had previously been found by RNA expression analysis to be downregulated in bladder cancer. Most importantly, epigenetically silenced ITIH5 was associated with early relapse in pT1 high grade tumors and functionally showed an enhanced invasive metastatic phenotype in tumor cells, suggesting a putative tumor suppressive role. Thus, epigenetic gene silencing is an additional mechanism of tumorigenesis especially in tumor progression.

Entities:  

Keywords:  Bladder cancer; Clonal relationship; DNA methylation; Field cancerization; Intraurothelial migration/tumor cell seeding

Mesh:

Substances:

Year:  2016        PMID: 27613302     DOI: 10.1007/s00292-016-0207-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

Review 1.  Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex.

Authors:  Lisheng Zhuo; Vincent C Hascall; Koji Kimata
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

2.  Hypermethylation in bladder cancer: biological pathways and translational applications.

Authors:  Marta Sánchez-Carbayo
Journal:  Tumour Biol       Date:  2012-01-25

Review 3.  Origins of Bladder Cancer.

Authors:  Bogdan Czerniak; Colin Dinney; David McConkey
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

4.  X-inactivation patch size in human female tissue confounds the assessment of tumor clonality.

Authors:  Marco Novelli; Antonio Cossu; Dahmane Oukrif; Alberto Quaglia; Sunil Lakhani; Richard Poulsom; Peter Sasieni; Piera Carta; Marcella Contini; Anna Pasca; Giuseppe Palmieri; Walter Bodmer; Francesco Tanda; Nick Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-27       Impact factor: 11.205

5.  Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.

Authors:  A Lopez-Beltran; J Alvarez-Kindelan; R J Luque; A Blanca; A Quintero; R Montironi; L Cheng; R Gonzalez-Campora; M J Requena
Journal:  J Pathol       Date:  2008-07       Impact factor: 7.996

6.  The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

Authors:  J Veeck; M Chorovicer; A Naami; E Breuer; M Zafrakas; N Bektas; M Dürst; G Kristiansen; P J Wild; A Hartmann; R Knuechel; E Dahl
Journal:  Oncogene       Date:  2007-07-23       Impact factor: 9.867

7.  Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.

Authors:  Michael Rose; Nadine T Gaisa; Pia Antony; David Fiedler; Axel Heidenreich; Wolfgang Otto; Stefan Denzinger; Simone Bertz; Arndt Hartmann; Alexander Karl; Ruth Knüchel; Edgar Dahl
Journal:  Carcinogenesis       Date:  2013-11-21       Impact factor: 4.944

8.  ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.

Authors:  Marina Himmelfarb; Eva Klopocki; Susanne Grube; Eike Staub; Irina Klaman; Bernd Hinzmann; Glen Kristiansen; André Rosenthal; Matthias Dürst; Edgar Dahl
Journal:  Cancer Lett       Date:  2004-02-10       Impact factor: 8.679

9.  Clonal origin of bladder cancer.

Authors:  D Sidransky; P Frost; A Von Eschenbach; R Oyasu; A C Preisinger; B Vogelstein
Journal:  N Engl J Med       Date:  1992-03-12       Impact factor: 91.245

10.  Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.

Authors:  J M Pita; A Banito; B M Cavaco; V Leite
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.